ENTITY

Decoy Therapeutics (DCOY US)

1
Analysis
Health CareUnited States
Decoy Therapeutics Inc. operates as a preclinical-stage biotechnology company. The Company specializes in drug development and manufacturing peptide conjugate therapeutics that focuses on respiratory viruses and GI cancers. Decoy Therapeutics serves customers in the United States.
more
Publication Icon
No publications yet
There aren’t any buy-side reports right now
Back to "All"
x